Current Report Filing (8-k)
May 09 2019 - 4:59PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 9, 2019
Pfenex Inc.
(Exact name
of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-36540
|
|
27-1356759
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
10790 Roselle Street
San Diego, CA 92121
(Address of principal executive offices, including zip code)
(858)
352-4400
(Registrants telephone number, including area code)
Not Applicable
(Former
name or former address, if changed since last report.)
Check the appropriate box below
if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17
CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or
Rule
12b-2
of the Securities Exchange Act of 1934 (17 CFR
§240.12b-2).
Emerging growth company ☒
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock, par value $0.001 per share
|
|
PFNX
|
|
NYSE American
|
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of
Principal Officers; Compensatory Arrangements of Certain Officers.
As noted below, on May 9, 2019, our stockholders approved the
amendment and restatement of our 2014 Equity Incentive Plan (1) to increase the number of shares of common stock reserved thereunder by 2,000,000 shares; and (2) to make such other changes as described in the proxy statement. The Amended
and Restated 2014 Equity Incentive Plan is described in more detail in the Companys 2019 Proxy Statement, which was filed with the Securities and Exchange Commission on April 4, 2019. The foregoing description and the summary contained in
the Companys 2019 Proxy Statement do not purport to be complete and are qualified in their entirety by reference to the full text of the Amended and Restated 2014 Equity Incentive Plan, which is attached hereto as Exhibit 10.1.
Item 5.07 Submission of Matters to a Vote of Security Holders.
We held our 2019 annual meeting of stockholders on May 9, 2019 (the Annual Meeting). Of the 31,485,199 shares of our common
stock outstanding as the record date of March 14, 2019, 29,934,557 shares were represented at the Annual Meeting, either in person or by proxy, constituting approximately 95% of the outstanding shares of common stock. The matters voted on at
the Annual Meeting and the votes cast with respect to each such matter are set forth below:
1.
|
Election of Class
II Directors.
Each of the following nominees was elected to
serve as a Class II director, to hold office until our 2022 annual meeting of stockholders or until his or her respective successor has been duly elected and qualified or his or her earlier resignation or removal based on the following results
of voting:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominee
|
|
Votes For
|
|
|
Votes Withheld
|
|
|
Broker Non-
Votes
|
|
Phillip M. Schneider
|
|
|
19,090,048
|
|
|
|
4,417,741
|
|
|
|
6,426,768
|
|
Robin D. Campbell, Ph.D.
|
|
|
18,740,261
|
|
|
|
4,767,528
|
|
|
|
6,426,768
|
|
Magda Marquet, Ph.D.
|
|
|
22,805,824
|
|
|
|
701,965
|
|
|
|
6,426,768
|
|
2.
|
Approval of Amended and Restated 2014 Equity Incentive Plan.
The amendment and restatement of the
Companys 2014 Equity Incentive Plan was approved, including (1) an increase in the number of shares of common stock reserved thereunder by 2,000,000 shares; and (2) such other changes as described in the Proxy Statement.
|
|
|
|
|
|
|
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|
Broker Non-
Votes
|
17,942,816
|
|
5,443,776
|
|
121,197
|
|
6,426,768
|
3.
|
Ratification of Appointment of Independent Registered Public Accounting Firm.
The appointment of
KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019 was ratified based on the following results of voting:
|
|
|
|
|
|
|
|
Votes For
|
|
Votes Against
|
|
Abstentions
|
|
Broker Non-
Votes
|
29,766,270
|
|
57,576
|
|
110,711
|
|
|
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
PFENEX INC.
|
|
|
|
|
Date: May 9, 2019
|
|
|
|
By:
|
|
/s/ Susan A. Knudson
|
|
|
|
|
|
|
Susan A. Knudson
|
|
|
|
|
|
|
Chief Financial Officer
(Principal
Financial Officer)
|
Pfenex (AMEX:PFNX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfenex (AMEX:PFNX)
Historical Stock Chart
From Apr 2023 to Apr 2024